CARB-X accelerates global antibacterial innovation by supporting the development of new antibiotics and other life-saving products. See contact routes.
CARB-X accelerates global antibacterial innovation by supporting the development of new antibiotics and other life-saving products to combat the most dangerous drug-resistant bacteria. Its portfolio represents the world’s most scientifically diverse, early development pipeline of new antibiotics, preventatives, rapid diagnostics, and other products to prevent, diagnose and treat life-threatening bacterial infections. CARB-X operates in 14 different countries.
StartupFundraising tracks this firm record from SEC filings and announced rounds, updating focus, location and portfolio history as new data lands. Use it to gauge fit before an outreach, then widen the search to investors in Boston.
Investors like Carb-X · Full investor directory · Investor access · Company funding database